Anne’s market predictions for 2019 featured in Chemist & Druggist 15-1-19
Anne’s market predictions for 2019 featured in Chemist & Druggist 15-1-19
This year at the Pharmacy Show in Birmingham, our team were delighted to welcome so many pharmacy owners and buyers to our stand. We enjoyed chatting about the current market and key factors currently concerning pharmacy owners at this time and discussing everything pharmacy! That was our 10th year at the pharmacy show and we look forward to continuing on building new relationships from this year and many more years to come.
Hutchings Consultants Ltd are delighted to announce that we have been formally instructed by the East of England Co-operative Society to bring to market their six Suffolk based pharmacies, three located in Ipswich and three further shops in Felixstowe, Stowmarket and Saxmundham. The pharmacies are being marketed ideally as a single group sale, however splitting the group may also be considered.
Nick Denny, Joint Chief Executive of the East of England Co-op said:
“We’ve appointed Hutchings Consultants Ltd to handle the sales process for us because they deal solely with pharmacies and have many years’ experience in the market. We are confident that they will find a buyer who will run these businesses for the benefit of our staff and communities.”
Luke Williams from Hutchings Consultants comments – “This is a fantastic opportunity for an experienced operator to gain a stronghold across Suffolk. All six pharmacies are well placed within the local communities offering potential for business development and operational streamlining. Despite the well documented remuneration cuts in England the pharmacy market is extremely buoyant and still regarded as a sellers’ market. This is due to insufficient pharmacies available to meet the high demand from purchasers.”
All enquiries about the East of England Co-operative Society pharmacies are to be directed to Luke Williams at Hutchings Consultants Ltd.
Contact details – [email protected] or 01494 722 224.
Many pharmacy owners decided to bring forward the sale of their business in 2017 following the announcement of funding cuts, leading to an incredibly busy year for brokers.
The following are just a few examples of pharmacies we sold for our clients across the UK last year, the results of which demonstrate the market has remained surprisingly buoyant.
Anne Hutchings advises on how independent pharmacy owners can increase the value of their pharmacies and cope with the funding cuts.
Whether you are buying your first pharmacy or about to sell up and retire, here are a few key tips which will help manage the sale process and minimise everyone’s stress levels.
If you are buying:
If you are selling:
Most importantly appoint good specialist pharmacy advisers to help you through the process.
In 2016, we achieved pharmacy goodwill values of between 5.9 and 17.3 times EBITDA (earnings before interest, tax, depreciation and amortisation). With such large variations in pharmacy prices it illustrates how important it is to market the pharmacy properly to achieve the maximum price.
An interesting thing is that by selling your pharmacy you can realise a substantial lump sum which would take you many years to earn as a pharmacist.
Take the example of a pharmacy we sold recently in the South East. This pharmacy had a turnover of £1.1m and EBITDA of £259,000. We obtained a goodwill value of £1.8m which was 7 times EBITDA. In terms of pence in the £1 this was £1.63.
The owner was entitled to entrepreneurs’ relief and therefore will only pay tax at 10% on the sale leaving them with £1,620,000 in their pocket.
If that pharmacy owner had continued trading instead of selling assuming that they were able to maintain the profit level at £259,000 per annum their net position after tax (using current tax rates) would be:
Annual profit £259,000
Corporation tax (51,800)
Tax on dividends (62,200)
Net income after tax £145,000
To earn £1,620,000 it would take them just over 11 years (£145,000 x 11.17).
We sold one pharmacy last year where the vendor would have had to work for another 20 years to make the same amount as he did from the proceeds of his pharmacy sale!
If you are thinking now may be the time to move on or release a lump sum for retirement, contact Anne or Scott for an informal discussion and a free valuation.
Scott Hayton, Director at Hutchings Consultants gives his view on the implications of the funding cuts.
“The decision by the Government announced by PSNC on Thursday 20th October has dashed the hopes of pharmacists, patients and other stakeholders across England, that the new pharmacy minister Mr Mowat would listen to the opinions, independent data and various petitions that have presented and gathered huge momentum across England over the last 10 months.
Having studied the figures released by PSNC on Thursday, the announcement appears to have confirmed the longstanding expectation within the market that the average pharmacy’s bottom line profit will be hit by around £15,000 following the cuts. In addition it has also confirmed that there will be further cuts in next year’s budget for 2017 – 2018.
On 20th October 2016, as part of the two-year final funding packing imposed upon community pharmacies in England, the Department of Health confirmed the introduction of a Pharmacy Access Scheme (PhAS), with the stated aim of ensuring that a baseline level of patient access to NHS community pharmacy services is protected. The Department of Health states that the PhAS will protect access in areas where there are fewer pharmacies with higher health needs, so that no area need be left without access to NHS community pharmaceutical services.
Qualifying pharmacies will receive £11,600 in 2016/17 and £17,600 in 2017/18 meaning those pharmacies will not feel the full effect of the reduction in funding from December 2016. At this point, the payments are guaranteed for 2 years but after 31st March 2018, it is not clear yet what will happen with this scheme.
Eligibility for the PhAS
Pharmacies do not need to apply to the scheme to be eligible; eligibility has been calculated nationally by the Department of Health, based on data relating to how many prescription items a pharmacy dispensed in 2015/16, to assess their size and data relating to the distances between pharmacies.
Is it time to sell and is selling the right thing to do? Ultimately, only you can answer these questions. Here are a few points to consider:
Factors such as interest rates, the availability of credit and the tax regime are outside your control. However, interest rates and availability of credit are two key factors for pharmacy buyers. With banks keen to lend to buyers and interest rates at historically low levels, acquiring a pharmacy is currently an attractive proposition.
Tax rates – on a business sale are favourable. For most pharmacy sellers the situation is straightforward: providing you qualify for Entrepreneur’s Relief – which most pharmacy owners do – you should only pay 10% capital gains tax on the sale of your business.
Government cuts – The squeeze on government spending has inevitably had an effect on pharmacy services. Despite an ageing population and a year-on-year increase in prescription items, pharmacy turnover has been fairly static in recent years. Pharmacy goodwill values though, have been holding up. What does the future hold for goodwill value? Continue reading
If you are thinking of selling, we offer a verbal valuation free of charge.
We also provide written valuations.
If you are considering the sale of your Pharmacy, Hutchings Consultants can help you.